Universal Vision Biotechnology Co., Ltd. announced the change of the principal financial and accounting officer of the Company. Name, title, and resume of the previous position holder: Principle financial and accounting officer: Sophia Lien (Substitute); Name, title, and resume of the new position holder: Principle financial and accounting officer: Cindy Sun, vice president of financial department of Grand Pacific Investment & Development Co., Ltd.; senior financial manager of Chailease Finance; and assurance services manager of PricewaterhouseCoopers Taiwan; Reason for the change: Position adjustment; Effective date is October 20, 2022.
Universal Vision Biotechnology Co., Ltd.
Equities
3218
TW0003218004
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
247.5 TWD | +0.41% | -2.94% | -10.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.65% | 645M | |
+22.39% | 43.96B | |
-0.30% | 18.75B | |
-20.50% | 2.22B | |
+25.60% | 2.11B | |
+19.17% | 1.13B | |
-38.32% | 716M | |
-44.53% | 632M | |
+57.22% | 606M | |
+17.51% | 494M |
- Stock Market
- Equities
- 3218 Stock
- News Universal Vision Biotechnology Co., Ltd.
- Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes